These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22920041)

  • 21. Hypocretin antagonists in insomnia treatment and beyond.
    Ruoff C; Cao M; Guilleminault C
    Curr Pharm Des; 2011; 17(15):1476-82. PubMed ID: 21476951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC; Guilleminault C
    Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of chronic insomnia in elderly persons.
    Bain KT
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and pharmacologic management options for insomnia.
    Benca RM
    Postgrad Med; 2004 Dec; 116(6 Suppl Insomnia):23-32. PubMed ID: 19667688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic and nonpharmacologic treatments of insomnia.
    Becker PM
    Neurol Clin; 2005 Nov; 23(4):1149-63. PubMed ID: 16243620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insomnia: Pharmacologic Therapy.
    Matheson E; Hainer BL
    Am Fam Physician; 2017 Jul; 96(1):29-35. PubMed ID: 28671376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications.
    Krystal AD; Richelson E; Roth T
    Sleep Med Rev; 2013 Aug; 17(4):263-72. PubMed ID: 23357028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining pharmacologic and nonpharmacologic therapies for insomnia.
    Mendelson WB
    J Clin Psychiatry; 2007; 68 Suppl 5():19-23. PubMed ID: 17539705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.
    Riemann D; Perlis ML
    Sleep Med Rev; 2009 Jun; 13(3):205-14. PubMed ID: 19201632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insomnia: drug therapies #105.
    Arnold RM; Miller M; Mehta RS
    J Palliat Med; 2012 Feb; 15(2):243-4. PubMed ID: 22339330
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologic treatment of pediatric insomnia.
    Owens JA; Moturi S
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):1001-16. PubMed ID: 19836701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Almorexant, a dual orexin receptor antagonist for the treatment of insomnia.
    Neubauer DN
    Curr Opin Investig Drugs; 2010 Jan; 11(1):101-10. PubMed ID: 20047164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of eszopiclone in the treatment of insomnia.
    Morin AK; Willett K
    Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
    Roecker AJ; Cox CD; Coleman PJ
    J Med Chem; 2016 Jan; 59(2):504-30. PubMed ID: 26317591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update of management of insomnia in patients with chronic orofacial pain.
    Almoznino G; Haviv Y; Sharav Y; Benoliel R
    Oral Dis; 2017 Nov; 23(8):1043-1051. PubMed ID: 28075519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia.
    Lankford A; Ancoli-Israel S
    Int J Clin Pract; 2007 Jun; 61(6):1037-45. PubMed ID: 17386060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey.
    Owens JA; Rosen CL; Mindell JA; Kirchner HL
    Sleep Med; 2010 Aug; 11(7):692-700. PubMed ID: 20621556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of compounds active in insomnia: recent developments and methodological aspects].
    Staner L; Luthringer R; Macher JP
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S48-55. PubMed ID: 14646800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.